Geode Capital Management
ELTX icon

Geode Capital Management’s Elicio Therapeutics ELTX Stock Holding History

Geode Capital Management’s Portfolio ELTX Stock Details ELTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.22M Buy
311,354
+176,190
+130% +$1.77M ﹤0.01% 3312
2026
Q1 		$1.45M Buy
135,164
+2,646
+2% +$25.5K ﹤0.01% 3239
2025
Q4 		$1.06M Buy
132,518
+2,832
+2% +$25.7K ﹤0.01% 3363
2025
Q3 		$1.42M Buy
129,686
+8,855
+7% +$89.6K ﹤0.01% 3294
2025
Q2 		$933K Buy
120,831
+43,364
+56% +$270K ﹤0.01% 3346
2025
Q1 		$477K Buy
77,467
+6,746
+10% +$52.3K ﹤0.01% 3561
2024
Q4 		$347K Sell
70,721
-853
-1% -$4.2K ﹤0.01% 3715
2024
Q3 		$360K Buy
71,574
+66
+0.1% +$292 ﹤0.01% 3705
2024
Q2 		$294K Buy
71,508
+23,812
+50% +$201K ﹤0.01% 3777
2024
Q1 		$363K Buy
47,696
+3,352
+8% +$16.8K ﹤0.01% 3725
2023
Q4 		$370K Buy
44,344
+16,470
+59% +$107K ﹤0.01% 3727
2023
Q3 		$236K Buy
27,874
+3,705
+15% +$35.3K ﹤0.01% 3914
2023
Q2 		$230K Buy
24,169
+7,429
+44% +$68.1K ﹤0.01% 3983
2023
Q1 		$97.1K Sell
16,740
-104
-0.6% -$693 ﹤0.01% 4344
2022
Q4 		$136K Sell
16,844
-45
-0.3% -$409 ﹤0.01% 4278
2022
Q3 		$155K Buy
16,889
+8,194
+94% +$85.6K ﹤0.01% 4348
2022
Q2 		$99K Sell
8,695
-15,893
-65% -$254K ﹤0.01% 4596
2022
Q1 		$521K Buy
24,588
+2,123
+9% +$47.9K ﹤0.01% 3914
2021
Q4 		$651K Sell
22,465
-2,707
-11% -$137K ﹤0.01% 3912
2021
Q3 		$2.46M Buy
25,172
+15,043
+149% +$1.63M ﹤0.01% 3261
2021
Q2 		$1.32M Buy
10,129
+598
+6% +$86.3K ﹤0.01% 3462
2021
Q1 		$1.72M Buy
+9,531
New +$1.84M ﹤0.01% 3327

Other funds holding ELTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management's ELTX Position: Q2 2026 in Review

Geode Capital Management increased its Elicio Therapeutics (ELTX) stake by 130% in Q2 2026, buying an estimated $1.77M and bringing the position to 311,354 shares worth $1.22M. The position accounts for ﹤0.01% of the portfolio, ranked #3312.

Geode Capital Management first reported a position in ELTX in Q1 2021 and has held it in 22 quarters since. The position peaked at $2.46M in Q3 2021. 46 funds tracked by Wall St. Rank hold ELTX as of Q2 2026.

  • Geode Capital Management held 311,354 shares of Elicio Therapeutics worth $1.22M as of Q2 2026.
  • Geode Capital Management bought 176,190 Elicio Therapeutics shares in Q2 2026, an estimated $1.77M.
  • Elicio Therapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3312 holding.
  • Geode Capital Management first reported a position in Elicio Therapeutics in Q1 2021 and has held it in 22 quarters since.
  • Geode Capital Management's Elicio Therapeutics position peaked at $2.46M in Q3 2021.
  • 46 funds tracked by Wall St. Rank held Elicio Therapeutics as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.